Abstract
摘要
相似文献
1
The bioavailability of digoxin.
Lancet. 1972 Aug 12;2(7772):311-2.
2
Variation in the biological availability of digoxin.
Lancet. 1972 Aug 12;2(7772):303-7. doi: 10.1016/s0140-6736(72)92908-x.
3
Bioavailability and digoxin.
N Z Med J. 1972 Sep;76(484):203.
4
Dissimilarities of digoxin.
N Engl J Med. 1971 Dec 9;285(24):1376-7. doi: 10.1056/NEJM197112092852414.
5
Biological availability of digoxin from Lanoxin produced in the United Kingdom.
Br Med J. 1973 Nov 10;4(5888):323-6. doi: 10.1136/bmj.4.5888.323.
6
Bioavailability of digoxin tablets.
Pharmacol Rev. 1973 Jun;25(2):229-37.
7
Non-equivalence of digoxin tablets.
Ann Clin Res. 1974;6(0):suppl 11:4-8.
8
Editorial: What the practicing physician should know about digoxin bioavailability and how will FDA action affect him?
Circulation. 1974 Mar;49(3):399-400. doi: 10.1161/01.cir.49.3.399.
9
Variation in biologic availability of digoxin from four preparations.
N Engl J Med. 1971 Dec 9;285(24):1344-7. doi: 10.1056/NEJM197112092852403.
10
Biological availability of digoxin.
Br Heart J. 1973 May;35(5):554-5.
Zotero 插件